go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

A.Menarini Pharmaceuticals Ltd
2nd Floor, Castlecourt, Monkstown, Monkstown, Co. Dublin, Ireland
Telephone: +353 1 284 6744
Fax: +353 1 284 6769
E-mail: ireland@menarini.ie
Medical Information Direct Line: 1800 283 045
Patient Information Leaflet last updated on medicines.ie: 24/01/2012
PIL Nebilet

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 24/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Addition of manufacturer
Updated on 24/06/2011 and displayed until 24/01/2012
Reasons for adding or updating:
  • Change of manufacturer
  • Change to date of revision
Updated on 30/03/2011 and displayed until 24/06/2011
Reasons for adding or updating:
  • Change to storage instructions
  • Change to drug interactions
  • Change to further information section
  • Change to date of revision
Updated on 24/07/2008 and displayed until 30/03/2011
Reasons for adding or updating:
  • Change to further information section
Updated on 05/06/2008 and displayed until 24/07/2008
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
Updated on 12/02/2008 and displayed until 05/06/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to improve clarity and readability
Updated on 23/11/2006 and displayed until 12/02/2008
Reasons for adding or updating:
  • Change to packaging
Updated on 13/06/2006 and displayed until 23/11/2006
Reasons for adding or updating:
  • Change to storage instructions
Updated on 03/04/2006 and displayed until 13/06/2006
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 07/02/2006 and displayed until 03/04/2006
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
  • Change to dosage and administration
Updated on 15/09/2005 and displayed until 07/02/2006
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 05/08/2004 and displayed until 15/09/2005
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  Nebivolol hydrochloride